These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 16702041)
1. Inhibition of platelet aggregation by grafting RGD and KGD sequences on the structural scaffold of small disulfide-rich proteins. Reiss S; Sieber M; Oberle V; Wentzel A; Spangenberg P; Claus R; Kolmar H; Lösche W Platelets; 2006 May; 17(3):153-7. PubMed ID: 16702041 [TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation. Okuda D; Morita T J Biochem; 2001 Sep; 130(3):407-15. PubMed ID: 11530017 [TBL] [Abstract][Full Text] [Related]
3. Cystine-knot peptides engineered with specificities for α(IIb)β(3) or α(IIb)β(3) and α(v)β(3) integrins are potent inhibitors of platelet aggregation. Silverman AP; Kariolis MS; Cochran JR J Mol Recognit; 2011; 24(1):127-35. PubMed ID: 21194123 [TBL] [Abstract][Full Text] [Related]
4. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. Scarborough RM; Naughton MA; Teng W; Rose JW; Phillips DR; Nannizzi L; Arfsten A; Campbell AM; Charo IF J Biol Chem; 1993 Jan; 268(2):1066-73. PubMed ID: 8419315 [TBL] [Abstract][Full Text] [Related]
7. Function of disintegrin-like/cysteine-rich domains of atrolysin A. Inhibition of platelet aggregation by recombinant protein and peptide antagonists. Jia LG; Wang XM; Shannon JD; Bjarnason JB; Fox JW J Biol Chem; 1997 May; 272(20):13094-102. PubMed ID: 9148922 [TBL] [Abstract][Full Text] [Related]
8. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins. McLane MA; Vijay-Kumar S; Marcinkiewicz C; Calvete JJ; Niewiarowski S FEBS Lett; 1996 Aug; 391(1-2):139-43. PubMed ID: 8706902 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the effect of decorsin and two disintegrins, albolabrin and eristostatin, on platelet function. McLane MA; Gabbeta J; Rao AK; Beviglia L; Lazarus RA; Niewiarowski S Thromb Haemost; 1995 Nov; 74(5):1316-22. PubMed ID: 8607116 [TBL] [Abstract][Full Text] [Related]
10. Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alpha IIb beta 3, alpha V beta 3 and alpha 5 beta 1 and in cell adhesion inhibition. Pfaff M; McLane MA; Beviglia L; Niewiarowski S; Timpl R Cell Adhes Commun; 1994 Dec; 2(6):491-501. PubMed ID: 7538018 [TBL] [Abstract][Full Text] [Related]
11. Amino acid sequence and homology modeling of obtustatin, a novel non-RGD-containing short disintegrin isolated from the venom of Vipera lebetina obtusa. Moreno-Murciano MP; Monleón D; Calvete JJ; Celda B; Marcinkiewicz C Protein Sci; 2003 Feb; 12(2):366-71. PubMed ID: 12538900 [TBL] [Abstract][Full Text] [Related]
12. Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn2+ cation. Rahman S; Aitken A; Flynn G; Formstone C; Savidge GF Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):247-57. PubMed ID: 9761721 [TBL] [Abstract][Full Text] [Related]